83 results
424B4
APVO
Aptevo Therapeutics Inc
12 Apr 24
Prospectus supplement with pricing info
5:23pm
-looking statements including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects … capabilities.
Our Strategy
We seek to grow our business by, among other things:
Advancing our lead clinical blood cancer candidate, APVO436, through
424B4
asv xcknntla3ik
3 Aug 23
Prospectus supplement with pricing info
5:21pm
8-K
EX-99.1
xj0szo c7k
18 Jul 23
Aptevo Announces Positive Duration of Remission Data
8:16am
S-1
y8wr8p9dc3 rcgw9b
30 Jun 23
IPO registration
4:16pm
8-K
EX-99.1
bmfyky djd1
12 Dec 22
Other Events
8:17am